The Stellar Foundation’s Current CEO is Now its Chief Architect
The news of her appointment was made known via a recent press release put out by the foundation.
The press release revealed that the foundation’s current executive director and co-founder of the foundation, Jed McCaleb, is now in charge of the network protocol and adoption strategy.
While working at the not-for-profit internet company, reports revealed that Dixon championed the firm’s fight for net neutrality and control over personal data.
Her experience leading operations, business and her work on policy at Mozilla will also be an added advantage to the crypto project.
Mozilla’s primary product is its web browser—Mozilla Firefox, which was released in September 2002 (closing in on 17 years).
Click here to read more about cryptocurrency news today
Mr. Kalpesh Patel, the Founder and CEO of Solution Analysts, has recently shared his insights in an interview conducted by TopDevelopers.
In his exclusive and candid interview, he talks about his company, his journey as a technopreneur, and his role in developing the business.
TopDevelopers is a reliable B2B research and review agency to help entrepreneurs connect with the top software solution providers.
Headquartered in Ahmedabad, today, the company has a global corporate office in the USA.
As per Mr. Kalpesh, the company’s focus always remains on the quality-driven agility while developing customized enterprise software.
In the eight years of journey, Solution Analysts has addressed diverse client requirements across various industry sectors and helps many startups to thrive with cost-effective services..
If you are searching for a business, then no need to go anywhere.
Boardroom International offers members networking opportunities with an international peer group of C-Suite and Board directors.
Allowing thought leadership and discussion around regulatory issues and current business trends.
NEW YORK, NY (August 8, 2019): The 20th International Conference on Alzheimer's Drug Discovery, a two-day interdisciplinary forum to be held September 16-17, 2019 in Jersey City, NJ, will bring together 20 top researchers to present a diversity of approaches and the latest on innovative treatments and diagnostics for Alzheimer's disease, related dementias and cognitive aging.
The Alzheimer's Drug Discovery Foundation (ADDF)-funded investigators and other guest speakers will share findings on both novel and repurposed drug programs and biomarkers at various stages of the pipeline.
The program will focus on four major topics that include: Small molecule approaches for Alzheimer's disease; Novel approaches for frontotemporal dementia; Clinical trials in Alzheimer's disease; Novel biomarker approaches.
"This year's conference is particularly significant," said Dr. Howard Fillit, ADDF's Founding Executive Director and Chief Science Officer.
"Research advances are rapidly bringing drug discovery closer to important and practical applications.
Several presentations will address new directions in academic and startup drug development programs, targeting a wide variety of areas including vascular pathology, calcium regulation, neuroprotection and inflammation."